SYROS PHARMACEUTICALS, INC. Long-Term Debt, Maturity, Year Five
SYROS PHARMACEUTICALS, INC. had Long-Term Debt, Maturity, Year Five of $3.33 million as of 2020-12-31, per its 10-K filed 2021-03-04.
Discontinued › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive · last filed 2021-03-04
- 2020-12-31: Long-Term Debt, Maturity, Year Five $3.33M.
- 2020-09-30: Long-Term Debt, Maturity, Year Five $1.67M.
- 2020-06-30: Long-Term Debt, Maturity, Year Five $10.00M.
- 2020-03-31: Long-Term Debt, Maturity, Year Five $10.00M.
| Period end | Long-Term Debt, Maturity, Year Five |
|---|---|
| 2020-12-31 | $3.33M 10-K · filed 2021-03-04 |
| 2020-09-30 | $1.67M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $10.00M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $10.00M 10-Q · filed 2020-05-07 |